Skip to content

AZN LSE

AstraZeneca

Description

AZN · LSE

AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

Wikipedia · CC BY-SA 4.0

Headquarters
GB
Website
Website

Structure of AstraZeneca

AstraZeneca

Company

8 connections
OwnershipInvestment and holdings
OwnProducts and technology
DownstreamCustomers
PeersCompetition and partners
ConstraintsRegulation and exposure
Relationship began2026
AstraZenecaCompany · 8 connections
Layer 1

DownstreamCustomers1

PeersCompetition and partners1

OwnershipInvestment and holdings4

OwnProducts and technology1

ConstraintsRegulation and exposure1

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

Showing 1 to 8 of 9

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1
announced investment in massachusetts$1 billion

AstraZeneca announced a $1 billion investment in Massachusetts

The White House news · 2026-10-09 03:44

View evidence
  • RegulatorThe White House news2026-10-09 03:44
    AstraZeneca announced a $1 billion investment in Massachusetts
    View source
FactEvidence 1
investment commitment in its most favored nation agreement$50 billion

under the $50 billion investment commitment it made in its Most Favored Nation agreement

The White House news · 2026-10-09 03:44

View evidence
  • RegulatorThe White House news2026-10-09 03:44
    under the $50 billion investment commitment it made in its Most Favored Nation agreement
    View source
FactEvidence 1
planned investment$1B or more

No public evidence summary is available.

Bisnow · 2026-10-09 02:05

View evidence
FactEvidence 1
planned net local workersroughly 1,000 workers

No public evidence summary is available.

Bisnow · 2026-10-09 02:05

View evidence
FactEvidence 1
planned increase in local workforce50%

No public evidence summary is available.

Bisnow · 2026-10-09 02:05

View evidence
FactEvidence 1
manufacturesCOVID-19 vaccine

No public evidence summary is available.

GDELT Global Knowledge Graph · 2026-10-09 03:00

View evidence
  • MediaGDELT Global Knowledge Graph2026-10-09 03:00
    View source

Showing 1 to 6 of 32

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Not available: Company signals · Financials · Filings · Guidance